iNANOD AS is a nanotechnology based anticancer drug developing company operating from Oslo Cancer Cluster Incubator established in 2016.  The objective is to increase efficacy of cancer drugs and to reduce unintended side-effects for cancer patients and maximize their longevity. We have a strong group of people to deliver on the promise which comprises of our collaborators, scientific advisors and business advisors.   Our aim is to become a pharmaceutical company for anti cancer nanomedicines.  We will take a comprehensive approach, using collaborative research from many small projects and existing literature and infrastructure. Our team consisting of experts within nanotechnology, biology, chemistry, pharmacy and medicine. Our partnerships with research institutions, makes us well suited for developing and commercialising this technology. As the focus is on improved delivery, the technology can greatly improve safety and efficacy of existing cancer drugs. Moreover, the costly development of new drugs will not be necessary. Monetisation and exit will therefore be available in an earlier phase than normal within pharmaceutical development, through selling IPR to established pharmaceutical companies after clinical phase IIa. The Norwegian Research Council has granted our pre-project application in NANO 2021 call and research has started in August 2017. Innovasjon Norge has also supported us with mentoring hours. We are a member of Oslo Cancer Cluster now.

Validé fully facilitates innovation projects from the early R&D phase until commercialization by providing expertise in technology management, startups, incubation, investment, IPR and IP portfolio management, transactions, technology marketing, prototyping, and product development. Validé is the official technology transfer office of 10 research institutes and responsible for the IP portfolio management and commercialization of their intellectual assets. Validé offers incubation services to high-tech startups including accelerator programs, office space and full service startup packages.

TargetEveryone is a specialist in multi-channel marketing, and offers a high-end marketing platform. Recruit and collect all your data into one place. Segment your data into groups, so that you can easily target your valuable customers with all your relevant campaigns. Distribute personal messages through your preferred channels like SMS, E-mail, Mobile Native Apps, Social Media and more. Automated insight-driven 1 to1 marketing just got easy!

ShareLab incubator is about to be established at Oslo Science Park in Oslo. This role as ShareLab Incubator Manager is a unique and highly rewarding opportunity to join a newly established laboratory based life science incubator, where the goal is to build a new generation of biotech startups in Norway. You will be joining a small team responsible for growing the ShareLab incubator into one of the leading life science incubation communities in the country.

With a groundbreaking range of Fitness and Physical rehabilitation products Crosstepper Me-Mover ApS is selling products globally to an engaged customer base. Aiming for aggressive growth and further global sales in the next years we are building a core team of highly skilled motivated people with ambition and growth potential. Crosstepper Me-Mover ApS is a Danish privately held company backed by a very solid and focused investor group. Crosstepper Me-Mover ApS has been under development since 2010 and was bought by the new investor group in 2020, now readying for ambitious goals.

At Nextfood, we are reshaping the plant-based food supply chain from farm to fork with large scale indoor farms combined with mini-farms in restaurants, catering, retail etc. Our computer controlled decentralised farm network grows deliciously fresh, locally produced, pesticide-free greens year-round to the benefit of flavour, health and climate. 1 m2 Nextfood farm corresponds to 200 m2 outdoor farm land and saves 98% water, more than 75% fertiliser and electrifies energy consumption. In turn addressing one of humanity’s greatest challenges: A sustainable high quality food supply for a rapidly growing urbanised population.

Mange små og mellemstore virksomheder kæmper i dag med en forældet digital tilstedeværelse, der ikke konverterer besøgende til kunder. Samtidig bliver manuelle arbejdsprocesser ofte en tidsrøver, der stjæler fokus fra kerneforretningen. Uden den rette tekniske indsigt bliver digital vækst ofte en uoverskuelig og dyr post på budgettet, hvor resultaterne udebliver. Companio er stiftet af Marcel med en klar mission: At hjælpe virksomheder med at vækste gennem professionelt webdesign og effektive digitale løsninger, der sparer tid og skaber målbare resultater. Jeg transformerer dine online platforme fra simple visitkort til aktive salgsmaskiner. Ved at kombinere æstetisk design med teknisk optimering sikrer jeg, at din virksomhed ikke blot bliver set, men også valgt af dine kunder. Med erfaring fra over 50 succesfulde projekter og en kundetilfredshed på 100%, bygger Companio på tillid og personligt engagement. Jeg ved, at din tid er vigtig, og derfor prioriterer jeg altid en hurtig respons og sørger for, at vi overholder alle aftaler til punkt og prikke. Jeg nørder de tekniske detaljer og de bagvedliggende systemer, så du kan fokusere trygt på din kerneforretning. Vi lader altid resultaterne føre ordet. Du kan se et udvalg af mine tidligere projekter og se, hvordan jeg har hjulpet andre virksomheder i mål på: https://companio.dk/cases

AuroraDelta is a Finland–Bangladesh innovation platform that builds multiple impact‑driven projects under one umbrella – from waste management and circular economy to smart ports, logistics, renewable energy, technology and skills development. Our goal is to connect Finnish expertise and financing with Bangladeshi growth sectors, creating commercially viable solutions that also deliver strong social and environmental impact. At this stage AuroraDelta is a pre‑startup initiative led by a Bangladeshi founder living in Finland, with experience in grassroots entrepreneurship, cross‑border business, and community leadership. We already have a portfolio of 6–7 project concepts, where waste management is only the first pilot, alongside ideas in port development, shipping, textiles, tech, renewable energy and financial inclusion. We are now looking for a mission‑aligned co‑founder who can help shape AuroraDelta into a real company: validating which projects to prioritize, building partnerships in Finland and Bangladesh, and preparing for funding. A strong fit could bring skills in business development, fundraising, impact investing, operations, or sector expertise (waste/circular economy, logistics, ports and shipping, energy, or digital platforms). You should be comfortable working in a very early‑stage, high‑uncertainty environment, co‑creating the vision, and taking ownership of pilots and investor outreach.

Behavix is on a mission to revolutionize how behavioral data is collected, analyzed, and utilized powering up the ResTech movement within Market Research industry. Headquartered in Helsinki with a strategic base in New York City, Behavix can helps panel companies and app/web publishers to start collecting deep and unique online behavioral data across the key digital platforms, while delivering value to data users with AI-driven data feed solutions.

Heibjerg is a Danish robotics startup developing autonomous, chemical-free robots for pavement and outdoor area maintenance. Our core product is an autonomous weeding robot that operates in complex environments such as cemeteries, housing associations, and parks. The robot combines advanced navigation, sensor fusion, and AI-based vision to reduce manual labour and environmental impact.

Only 7.9% of new medicin is approved for phase 1 clinical programs - life saving cures are being scrapped because of poor reproducibility. Today, researchers designing complex in vitro and in vivo experiments jump between many tools that do not talk to each other. Protocols are written in free text, naming is inconsistent, raw data is scattered across drives, and inventory and cell banks are tracked separately. This makes it hard to reproduce experiments, compare results across projects, trace which cell material went into which batch, and satisfy regulatory expectations. Small and mid-sized labs often cannot afford enterprise platforms like Benchling or Dotmatics, so they manually glue everything together and rarely get to use advanced analytics or AI. BioPilot solves this by standardising the full early-to-in-vivo CTR pipeline in one product. Users can register and template in vitro experiments (differentiation, expansion, cryopreservation, device testing, etc.) and in vivo studies (animals, groups, dosing, housing, ethics documents) using fixed ontologies. This gives every experiment a structured schema and a precise schedule of readouts, barcodes and data types to collect. Raw data (FACS, scRNA-seq, imaging, counters, bioreactor logs, etc.) is then automatically linked back to the right experiment, condition and sample. On top of this, BioPilot offers: • Inventory and cell bank tracking that makes it trivial to trace which vial, edit or expansion batch was used where. • Live bioreactor monitoring with alarms (email / phone) to prevent losing expensive batches. • A growing library of free analytical tools, including automated FACS gating, scRNA-seq pipelines and image analysis that can feed results straight back into the experiment records. • A global ontology service for vendors, instruments, cell lines, species and process terms, with a roadmap for a public API. Because everything is structured and queryable, BioPilot makes it much easier to compare experiments, run Bayesian optimisation on process parameters, and let AI suggest next-step experiments. The pricing is kept aggressively low (free tier plus a simple paid tier based on storage), so smaller biotech and academic groups can access capabilities that are normally reserved for organisations with large software budgets. In short, BioPilot aims to become the operating system for cell therapy R&D: a single, affordable platform where experiments are planned, executed, monitored and analysed in a way that is standardised enough for automation and flexible enough for real-world biology.

We’re a community organisation aiming to build a world-class startup ecosystem in Aarhus backed by amazing stakeholders such as Aarhus University, Business Academy Aarhus, VIA University, The City Council of Aarhus, and Region Midtjylland. At Startup Aarhus we initiate programs and activities, that help solve our founder’s biggest challenges. Whether it’s securing funding, building networks, or gaining insights, we’re here to help you move forward, and make it easier for startups to change the world.

Nyx is a cloud-based nightclub management platform designed to streamline operations for venues and enhance the nightlife experience for guests. It offers a suite of tools including membership management, table booking, ticket sales, and guest list handling, all integrated into a single system. For venues, Nyx provides a comprehensive suite of features to manage daily operations efficiently. The platform allows for the creation of custom membership systems, enabling venues to offer unique perks and engage with their audience through push notifications, emails, or text messages. The table booking system offers a visual overview of the venue, handling orders, payments, credits, and bookings, all integrated with the membership system to provide a seamless experience. The ticket system facilitates the sale of event tickets or regular covers, with integration into the members app for a consistent user experience. For guests, Nyx serves as a digital wallet for nightclub membership cards, allowing users to discover clubs, register using their Nyx account, obtain memberships, buy tickets, and stay updated on events and news from their favorite venues. Nyx's flexible pricing model caters to venues of all sizes, with a starting price of €29 per month, and additional costs based on the number of members and active logins. The platform is available on both iOS and Android, ensuring accessibility for all users. With over 200 venues and more than 400,000 registered members, Nyx is redefining the way nightclubs manage their operations and connect with their audience.

Story-Lab Learning is a new kind of content agency built for the AI era. We create short, animated, and interactive learning modules – crafted by humans, powered by AI. Our focus is on microlearning that fits naturally into the workflow, using tools like We Are Learning, HeyGen, Vyond and more. We help companies train employees, partners, and customers through explainer videos, mini-scenarios, and immersive content. Our clients include Enterprises, EdTech platforms, LMS providers, HR/learning teams, and consultancies. We’re not just content creators — we’re also proud resellers of best-of-breed content creation tools like We Are Learning, enabling us and our partners to stay ahead of the curve in immersive and efficient learning production. Story-Lab is currently in an exciting early stage, with traction, great tools, and a growing network of collaborators. Now we’re looking for the right people to help us scale — and shape the future of learning. Anders Börde – Founder of Story-Lab Learning Anders is a EdTech entrepreneur with a strong track record of building digital learning ventures across the Nordics. He has held key roles at Telenor and founded Moblrn, as well as led international sales at We Are Learning – a pioneering platform for AI-driven 3D learning content. Anders combines strategic insight with hands-on execution and has helped global enterprises scale modern learning solutions. At Story-Lab Learning, he brings together creativity, technology, and AI to shape the future of microlearning.

Dalea delivers a data platform for research within BioPharma and Life Sciences, providing familiar tools and a frictionless migration for researchers. Researchers forecast industry data volumes will double within 1 year, yet 60% of data is currently still stored on personal computers or in physical notebooks. Despite this issue, there is a clear market gap; two thirds of researchers within the field are dissatisfied with existing options on the market today. This is a major challenge for data replication and scientific collaboration. It stifles the value of created data and greatly inhibits discovery. Larger BioPharma companies resort to re-running experiments, as a faster alternative to looking up results. The market size for Electronic Notebooks and Laboratory Information Management Systems is expected to double in the next 10 years, with industry leaders breaking a staggering $6 billion valuation. Dalea is entirely EU-based, ensuring current and future compliance and data security. Our Academic version launches this Autumn, with an initial customer base secured through partnerships with leading academic labs. Ready to revolutionize research data? Explore our open roles and join us on the front lines of scientific innovation.